Source:http://linkedlifedata.com/resource/pubmed/id/14996770
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2004-3-3
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1538-3598
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
3
|
pubmed:volume |
291
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1066-7; author reply 1067
|
pubmed:dateRevised |
2006-11-7
|
pubmed:meshHeading |
pubmed-meshheading:14996770-Bronchodilator Agents,
pubmed-meshheading:14996770-Cholinergic Antagonists,
pubmed-meshheading:14996770-Humans,
pubmed-meshheading:14996770-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:14996770-Research Design,
pubmed-meshheading:14996770-Scopolamine Derivatives
|
pubmed:year |
2004
|
pubmed:articleTitle |
Management of chronic obstructive pulmonary disease.
|
pubmed:publicationType |
Letter,
Comment
|